Safety Concerns About Saltz Regimen Were Statistical Artifact, ODAC Finds.
AACI: von Eschenbach “Wonderful Choice” For NCI Director, Knows How Centers Work. Cancer Centers Pleased With Bush Choice For NCI.
Campus-Dweller Rabson Finds Comfort In NIH Security.
Endostatin Enters Phase II Trial For Neuroendocrine Tumors.
Siemens To Provide Technology To DxTx For Lung Cancer Detection.
Myriad In Partnership To Market Products.
Computer-Aided Detection Approved For Mammograms.
Trending Stories
- Maura Gillison, who identified the role of HPV in head and neck cancer, changing the standard of care, dies at 61
- Johnson and Johnson reaches $5.5B settlement deal over talc lawsuits
- What happened at FDA? Replimune approval raises questions
- I grew up unhoused. Now, with support from ACS, I am an MD-PhD student focused on oncology
My mother instilled in me: “Never become a product of your circumstances.” - Duke Officials Silenced Med Student Who Reported Trouble in Anil Potti’s Lab
- FDA grants Replimune’s RP1 an accelerated approval on third submission after 10:3 vote from advisory committee
Amid political outcry, advisors accept weak data and give sponsor a chance to complete phase III trial









